<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mosley, Mary</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Elisei, Rossella</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Thyroid Cancer: New Diagnostic Approaches</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">22-23</style></pages><abstract><style  face="normal" font="default" size="100%">Molecular testing of thyroid nodules for genetic mutations is being used to augment fine-needle aspiration cytology to improve the accuracy of diagnosing thyroid cancer in the ∼?25% of thyroid nodules with indeterminate cytology. In this article, commercially available molecular diagnostic methods, as well as the diagnosis of thyroid nodular disease.</style></abstract><number><style face="normal" font="default" size="100%">20</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>